Trial Profile
Evaluation of ESBA105 in the Persistent Relief of Ocular Discomfort in Patients With Severe Dry Eye
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2014
Price :
$35
*
At a glance
- Drugs ESBA-105 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Alcon
- 27 Jun 2014 New trial record